Key points are not available for this paper at this time.
Adjunctive BRV at a daily dose of 50 mg was associated with statistically significant reductions in seizure frequency compared with PBO. All doses of BRV showed good tolerability throughout the study.
Biton et al. (Fri,) studied this question.